Here is a very recent discussion between some highly regarded individuals within the ophthalmology space regarding the benefits of combining canaloplasty with a stent -- meaning that EYE may not necessarily have to compete with Glaukos and instead, will benefit from the success of iStent
Viscodilation in the Canal - Eyetube
-
- There are more pages in this discussion • 3,086 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.003(1.89%) |
Mkt cap ! $38.35M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.0¢ | $136.6K | 999.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5475 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 1086456 | 2 |
View Market Depth
| Last trade - 13.45pm 18/07/2025 (20 minute delay) ? |
| EYE (ASX) Chart |